InspireMD, Inc. — Director's Dealing 2020

Oct 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2020-10-16

Reporting Person: ROUBIN GARY S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-16	Common Stock	P	222223	$0.45	Acquired	461173	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-16	Warrants	$0.495	P	222223	Acquired	2025-10-16	Common Stock (222223)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Stock	$0.33	2030-10-12	Common Stock (79650)	79650	Direct

Footnotes

F1: The Reporting Person purchased, in a private placement transaction, 222,223 shares of common stock and 222,223 warrants to purchase common stock together, as part of 222,223 units, at a purchase price of $0.45 per unit.

F2: 238,950 of these shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service.

F3: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F4: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 12, 2021, October 12, 2022 and October 12, 2023, subject to the Reporting Person's continued service.